Glucagon-like peptide-1 receptor analog use is associated with reduced thromboembolic events compared with dipeptidyl peptidase-4 inhibitors in rheumatoid arthritis patients: A global retrospective cohort study.

GLP-1 受體類似劑在類風濕性關節炎患者中相較於 DPP-4 抑制劑可降低血栓栓塞事件：一項全球回溯性世代研究